Ferring - Crunchbase Company Profile & Funding

Q: Where is Ferring's headquarters?

Ferring is located in Saint-prex, Vaud, Switzerland.

Q: When was the last funding round for Ferring?

Ferring closed its last funding round on obfuscated from a Debt Financing round.

Overview

Ferring

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ferring

CB Rank

9563

Ferring is a biopharmaceutical company that develops reproductive medicine for healthacare sectors.

Founded

obfuscation

Private

Debt Financing

Saint-prex, Vaud, Switzerland

5001-10000

www.ferring.com

Biotechnology

Manufacturing

Pharmaceutical

Funding Rounds

Debt Financing

OBF

obfuscation

Key People

Herve Udriot: Senior Vice President Manufacturing
Patrik Rojecki: Sr. Category Manager API & Excipients

Details

Legal Name

Ferring International Center S.A.

Operating Status

Active

Number of Exits

obfuscation

Company Type

For Profit

Founders

Frederik Paulsen

About the Company

Ferring is a biopharmaceutical company that specializes in reproductive health, maternal health, gastroenterology, and urology. They specialize in reproductive medicine and maternal health, and in specialty areas within gastroenterology and orthopedics.

Phone Number

+41 58 301 00 00

Contact Email

info@ferring.com

Predictions & Insights

Growth Insight

See this Growth Insight

Ferring is

Lorem

to be growing

Top Contributing Factors

Market Share Decline

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Rekovelle® (follitropin delta)

A recombinant follicle-stimulating hormone used in fertility treatments to stimulate ovarian follicle development.

Adstiladrin® (nadofaragene firadenovec-vncg)

A gene therapy for treating high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer.

Research & Development

Ferring is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Ferring	—	obfuscated obfuscation	—	Debt Financing

Investors

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation
obfuscated obfuscation	Robyn	Yes	Corporate Round - Robyn	obfuscated obfuscation